• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Dicerna Pharmaceuticals Inc

+ Add to Watchlist


16.4100 USD 0.1100 0.67%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Dicerna Pharmaceuticals Inc (DRNA)

Open: 16.4100 Day's Range: 15.8000 - 17.3700 Volume: 196,031
Previous Close: 16.3000 52wk Range: 15.0000 - 46.0000 1-Yr Rtn: -

Stock Chart for DRNA

No chart data available.
  • DRNA:US 16.4100
  • 1D
  • 1M
  • 1Y
Interactive DRNA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DRNA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.8950
Est. PEG Ratio -
Market Cap (M USD) 291.36
Shares Outstanding (M) 17.76
30 Day Average Volume 238,271
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DRNA

No data available

Company Profile & Key Executives for DRNA

Dicerna Pharmaceuticals, Inc. provides biopharmaceutical products. The Company discovers and develops ribonucleic acid interference drugs for the treatment of rare inherited diseases involving the liver and for cancers that are gentically defined. Dicerna Pharmaceuticals offers its products to the medical industry around the world.

Douglas M Fambrough IIIPresident/CEO/Co-FounderJames E Dentzer "Jim"Chief Financial Officer
James B WeissmanChief Business OfficerPankaj BhargavaChief Medical Officer
More Company Profile & Key Executives for DRNA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil